Efficacy News and Research

RSS

Study identifies improved treatment option for neuroblastoma

Neuroblastoma is a rare form of malignant tumor, primarily affecting children under the age of six. A research team led by molecular pathologist Lukas Kenner from MedUni Vienna's Department of Pathology has now discovered, through genome sequencing, that the protein ALK and the cancer gene PIM1 are involved in the development of this tumor.

4 Dec 2019

Newer safer way to effectively treat deadly brain cancer

A new engineering solution may help deliver tumor killing drugs directly to the brain tumor without the toxic body effects of systemic chemotherapy. The new study published in the journal Nature Scientific Reports reports on the use of coaxial electrospinning, an industrial fabrication technology, in the production of membranes that incorporate drugs to treat glioblastoma multiforme (GBM), an aggressive cancer of the brain.

3 Dec 2019

Study reveals effectiveness of single-dose radiotherapy for cancer in the spine

A single dose of radiotherapy is as "effective" as five doses for end-of-life cancer patients suffering with painful spinal canal compression, finds a large study conducted by UCL.

3 Dec 2019

Aspirin can be considered an effective and safe option to treat acute migraines

According to a new report in The American Journal of Medicine, published by Elsevier, aspirin can be considered an effective and safe option to other, more expensive medications to treat acute migraines as well as prevent recurrent attacks.

3 Dec 2019

Roswell Park-led scientists identify new defense mechanism against prostate cancer

A research team led by a scientist at Roswell Park Comprehensive Cancer Center has identified the molecule LRIG1 as an important endogenous tumor suppressor in prostate cancer. Writing in the journal Nature Communications, the team documents their findings from preclinical studies showing that overexpression of the LRIG1 protein inhibits prostate cancer development, while reducing naturally occurring LRIG1 promotes prostate tumor development.

3 Dec 2019

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

The growing trend of implementing immunotherapy into oncology has resulted in various new therapeutic cancer treatments utilizing antibodies.

From Sartorius 3 Dec 2019

Clinical trial data demonstrates safety and efficacy of nasal congestion treatment device

Healthy Humming, LLC is pleased to announce positive topline data from a prospective outcomes study, which assessed the safety and efficacy of the SinuSonic, a nasal congestion treatment device that combines nasal acoustic vibration with oscillating expiratory pressure.

3 Dec 2019

Low-cost intervention can increase self-esteem of young cancer survivors

Young cancer survivors face unique medical and psychosocial challenges that can hinder their ability to move on mentally and socially, even years after their final treatment.

2 Dec 2019

Hyperfine joins with Penn Medicine to assess new device for imaging hydrocephalus patients

Hyperfine Research Inc. has joined with Penn Medicine in a clinical research study of the world's first portable, low-cost magnetic resonance imaging system. This collaboration will examine the efficacy of the Hyperfine device in the care of patients with hydrocephalus.

2 Dec 2019

Stem cell therapy shows promise for the first time in spinal cord injury

Researchers have published the results of their work where stem cell therapy has shown promise in a case of spinal cord injury. The results of their case study were published in the latest issue of the journal Mayo Clinic Proceedings last week.

2 Dec 2019

MRI-guided ultrasound ablation: safer better treatment for prostate cancer

Prostate cancer may soon be treated more effectively using ultrasound at therapeutic levels, without the significant and distressing side effects of more traditional treatments. A new study presented on December 2, 2019, presents the outcome of using focused ultrasound ablation under MRI guidance in a novel procedure that can be used to treat both benign and malignant enlargement of the prostate gland.

2 Dec 2019

Consortium launches ambitious project to transform the treatment of pain

In an effort to address the critical public health need for new, safer and more effective medicines to treat pain, a consortium based at the Laboratory of Systems Pharmacology at Harvard Medical School has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation).

2 Dec 2019

Trial comparing three drugs for status epilepticus

Status epilepticus is a condition that is characterized by repeated seizures and is a medical emergency. Treatment is usually with a Benzodiazepine such as Diazepam or Lorazepam etc. There have been not any studies that look at the comparative benefit of drugs that could be prescribed for those who do not respond to the benzodiazepines. The study titled, “Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus,” was published in the latest issue of the journal New England Journal of Medicine.

1 Dec 2019

New vaccine against bovine TB

A new study published in the journal Scientific Reports says that for the first time a vaccine has been created against bovine tuberculosis that can be given without affecting the ability to diagnose tuberculosis later using the PPD skin test.

28 Nov 2019

NIH Statement for World AIDS Day outlines efforts to end the HIV epidemic

With World AIDS Day on 1st December, we are reminded by the NIH of the work that needs to be done to end the HIV Epidemic.

28 Nov 2019

Review: Benefits, safety of fortifying wheat or maize flour with folic acid and health outcomes

Folate is an essential B-vitamin that is needed for DNA synthesis and cell division. Folate deficiency can lead to anemia, and deficiency early in pregnancy can lead to neural tube defects – birth defects of the brain, spine and spinal cord, including spina bifida.

27 Nov 2019

New compound may enhance dengue vaccine efficacy by simulating amino acid deficiency

A new study published in the journal Science Signaling on November 26, 2019, describes a mouse experiment, in which the immune response to the dengue vaccine was boosted when the mice were first given halofuginone, a plant compound that is well known to herbalists.

27 Nov 2019

Study shows potential of hydromethylthionine treatment for Alzheimer's disease

In a paper published in today's online issue of the Journal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer's disease.

27 Nov 2019

Researchers move closer to new screening technology for early detection of Parkinson's disease

Screening technology to catch Parkinson's disease in its earliest stages could be available within three years, following an agreement between RMIT University and start-up company Jesse Medical.

27 Nov 2019

Sanitization error might possibly have exposed hundreds to HIV at Indiana hospital

An Indiana hospital is in the news for all the wrong reasons. An accidental failure by one of the seven sterilization technicians working at the hospital was recently discovered. The technician failed to carry out a single step in a protocol concerning the sanitization of surgical equipment at Goshen Hospital, over a period from April 1 to September 30.

26 Nov 2019